Roche Holding reports strong growth: what it means for Roche Holding stock
Published on 10/24/2026 at 10:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSSales and trading context
- Roche reported third-quarter sales growth of 7 percent at constant exchange rates on October 22, 2026.
- Roche Holding stock traded at EUR 436.23 at 10:14 a.m. CEST in weekend trading at Lang & Schwarz on October 24, 2026.
- The next Xetra session is scheduled for October 26, 2026.
Roche reported third-quarter sales growth of 7 percent at constant exchange rates and 8 percent in Swiss francs in an announcement dated October 22, 2026. The company also reported that group sales increased 6 percent at constant exchange rates to CHF 46.5 billion in the first nine months of 2026 and confirmed its full-year outlook. The announcement was published by Roche.
Roche Holding stock traded at EUR 436.23 at 10:14 a.m. CEST on October 24, 2026, in weekend trading at Lang & Schwarz. The bid was EUR 434.85 and the ask was EUR 437.60.
Market context: Market report SMI.
Roche reports third-quarter sales growth
For the first nine months of 2026, the Pharmaceuticals Division generated sales of CHF 36.2 billion, up 7 percent at constant exchange rates and 2 percent in Swiss francs. Diagnostics Division sales rose 4 percent at constant exchange rates to CHF 10.3 billion. Roche said its 2026 outlook calls for group sales growth in the mid-single-digit range at constant exchange rates and high-single-digit growth in core earnings per share at constant exchange rates. These figures and targets were included in the issuer announcement distributed by GlobeNewswire.
Roche also said it expects to further increase its dividend in Swiss francs. The next Xetra session is scheduled for October 26, 2026. The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Roche Holding stock.
